Abstract Neurological impairment is an important cause of dysphagia. This study analyzed whether quality of life (QoL) is improved after coblation-assisted endoscopic cricopharyngeal myotomy (CAECPM) for patients with persistent neurological dysphagia who meet the criteria by using the Chinese version of the Swallow Quality-of-Life Questionnaire (CSWAL-QOL). 22 patients with dysphagia for more than 6 months after stroke or lateral skull base surgery were screened. All patients...
Mon Jul 01, 2019 03:00
Related ArticlesQuality of Life in Treating Persistent Neurogenic Dysphagia with Cricopharyngeal Myotomy. Dysphagia. 2019 Jul 01;: Authors: Jin X, Gu W, Li W, Wang J Abstract Neurological impairment is an important cause of dysphagia. This study analyzed whether quality of life (QoL) is improved after coblation-assisted endoscopic cricopharyngeal myotomy (CAECPM) for patients with persistent neurological dysphagia who meet the criteria by using the Chinese...
Wed Jul 03, 2019 14:50
Related ArticlesThe Importance of Labyrinthine Examination in the Prognosis and Therapy for Balance in Spinocerebellar Ataxia. Int Tinnitus J. 2017 Apr 19;20(2):93-101 Authors: Faryniuk JH, Zeigelboim BS, Teive HAG, Fo VR, Liberalesso PBN, Marques JM Abstract INTRODUCTION: Spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative diseases that are characterized by the presence of progressive cerebellar ataxia. OBJECTIVE:...
Wed Jul 03, 2019 14:50
Related ArticlesDigital planning workflow for partial maxillectomy using an osteotomy template and immediate rehabilitation of maxillary Brown II defects with prosthesis. J Oral Rehabil. 2019 Jul 01;: Authors: Wang Y, Yang X, Gan R, Liu H, Wu G, Yu Q, Wang Z, Lu X, Jing J, Ma W, Quan Y, Sun Z, Fan L, Wang Y Abstract BACKGROUND: There is increasing evidence of benefits for the rehabilitation of Brown II defects with prosthesis in surgery. However, the...
Tue Jul 02, 2019 16:09
Related ArticlesFive-parameter evaluation of dysphagia: A novel prognostic scale for assessing neurological decline in Gaucher disease type 2. Mol Genet Metab. 2019 Jun 08;: Authors: Seehra G, Solomon B, Ryan E, Steward AM, Roshan Lal T, Tanima Y, Lopez G, Sidransky E Abstract BACKGROUND: Gaucher disease type 2 (GD2) is defined by acute neurological decline, failure to thrive, and early demise. Currently, there is no clear standard for evaluating, staging,...
Tue Jul 02, 2019 14:05
Related ArticlesRespiratory hospital admissions and emergency department visits in young people with cerebral palsy: 5-year follow-up. Arch Dis Child. 2019 Jun 29;: Authors: Blackmore AM, Bear N, Langdon K, Moshovis L, Gibson N, Wilson A PMID: 31256055 [PubMed - as supplied by publisher]
Mon Jul 01, 2019 15:25
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου